✨
AI Summary
- MASLD affects one in three adults, often undiagnosed until advanced stages.
- Discusses screening criteria: FIB-4, elastography, and hepatology referral.
- Examines MAESTRO-NASH & ESSENCE trials for MASH treatment advancements.